Kinetics of disease progression and host response in a rat model of bubonic plague

American Journal of Pathology

Volumn 166, Issue 5, 2005, Pages 1427-1439

  Sebbane, Florent ^a   Gardner, Donald ^a   Long, Daniel ^a   Gowen, Brian B ^a,b   Hinnebusch, B Joseph ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD LEVEL; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; FLEA; GRAM NEGATIVE BACTERIUM; HISTOPATHOLOGY; IMMUNE RESPONSE; KINETICS; LYMPHADENITIS; MOUSE; NONHUMAN; PATHOGENESIS; PLAGUE; PRIORITY JOURNAL; SEPTICEMIA; SPLEEN; YERSINIA PESTIS; ZOONOSIS;

EID: 17844375136     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62360-7     Document Type: Article

References (47)

1. Pollitzer R: Plague. Geneva, World Health Organization, 1954
2. Butler T: Plague and Other Yersinia Infections. New York, Plenum Press, 1983
3. Crowell BC: Pathologic anatomy of bubonic plague. Philipp J Sci 1915, 10:249-306
4. Flexner S: The pathology of bubonic plague. Am J Med Sci 1901, 122:396-416
5. Donavan JE, Ham D, Fukui GM, Surgalla MJ: Role of the capsule of Pasteurella pestis in bubonic plague in the guinea pig. J Infect Dis 1961, 109:154-157
6. Cornil J, Poursines Y, Moustardier G: La peste expérimental du cobaye et du rat blanc (données anatomo-cliniques). Méd Trop 1944, 4:111-129
7. Kitasato S: The bacillus of bubonic plague. Lancet 1894, ii:428-429
8. Devignat R, Shoetter M, Gille-Simul S: Quelques considerations sur la peste du cobaye. Rec Trav Sci Méd Congo Belge 1945, 4:25-34
9. Markenson J, Ben-Efraim S: Comportement in vivo des souches de Pasteurella pestis en relation avec leur éfficacité comme vaccins vivants. Ann Inst Pasteur 1969, 117:196-212
10. Meyer KF: Immunity in plague: a critical consideration of some recent studies. J Immunol 1950, 64:139-163
11. Chen TH, Meyer KF: Susceptibility and antibody response of Rattus species to experimental plague. J Infect Dis 1974, 129 (Suppl):S53-S61
12. Jones SM, Day F, Stagg AJ, Williamson ED: Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 2000, 19:358-366
13. Heath DG, Anderson GW Jr, Mauro JM, Welkos SL, Andrews GP, Adamovicz J, Friedlander AM: Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1993, 16:1131-1137
14. Perry RD, Fetherston JD: Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997, 10:35-66
15. Jawetz E, Meyer KF: The behaviour of virulent and avirulent Pasteurella pestis in normal and immune experimental animals. J Infect Dis 1943, 74:1-13
16. Gibbs RA, WeinstocK GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera, Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Foster C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahiil P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M, Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman VJC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Cooney AJ, D'Souza LM, Martin K, Wu JO, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichter EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar Alba M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O, Poliakov A, Hubner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ, Bromberg S, Gullings-Handley J, Jensen-Seaman MI, Kwitek AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S, Goodstadt L, Beatson SA, Ernes RD, Winter EE, Webber C, Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD, Caccamo M, Clamp M, Clarke L, Curwen V, Durbin R, Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Payseur BA, Bourque G, Lopez-Otin C, Puente XS, Chakrabarti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tester G, Pevzner PA, Haussier D, Roskin KM, Baertsch R, Clawson H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S, Coilins F: Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004, 428:493-521
17. Chen TH, Foster LE, Meyer KF: Experimental comparison of the immunogenicity of antigens in the residue of ultrasonated avirulent Pasteurella pestis with the vaccine prepared with the killed virulent whole organisms. J Immunol 1961, 87:64-71
18. Jarrett CO, Deak E, Isherwood KE, Oyston PC, Fischer ER, Whitney AR, Kobayashi SD, Deleo FR, Hinnebusch BJ: Transmission of Yersinia pestis from an infectious biofilm in the flea vector. J Infect Dis 2004, 190:783-792
19. Davidsohn I, Nelson DA, Henry JB: Blood. Clinical Diagnosis by Laboratory Methods, ed 15. Edited by I Davidsohn, JB Henry. Philadelphia, WB Saunders, 1974, pp 100-310
20. Hinnebusch BJ: Interactions of Yersinia pestis with its flea vector that lead to the transmission of plague. Microbe-Vector Interactions in Vector-Borne Disease. Edited by S Gillespie, G Smith, A Osbourn, Cambridge, UK, Cambridge University Press, 2004, pp 331-343
21. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP, Stainier I: The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 1998, 62:1315-1352
22. Ruckdeschel K, Rouot B, Heesemann J: Type III protein secretion and inhibition of NF-kB. Bacterial Evasion of Host Immune Responses. Edited by B Henderson, PFC Oyston. Cambridge, UK, Cambridge University Press, 2003, pp 279-294
23. Brubaker RR: Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003, 71:3673-3681
24. Mills SD, Boland A, Sory MP, van der Smissen P, Kerbourch C, Finlay BB, Cornelis GR: Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci USA 1997, 94:12638-12643
25. Monack DM, Mecsas J, Bouley D, Falkow S: Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 1998, 188:2127-2137
26. Ruckdeschel K, Roggenkamp A, Lafont V, Mangeat P, Heesemann J, Rouot B: Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun 1997, 65:4813-4821
27. Butler T, Bell WR, Nguyen Ngoc L, Nguyen Dinh T, Arnold K: Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis 1974, 129(Suppl):S78-S84
28. Butler T: A clinical study of bubonic plague: observations of the 1970 Vietnam epidemic with emphasis on coagulation studies, skin histology and electrocardiograms. Am J Med 1972, 53:268-276
29. Titball RW, Hill J, Lawton DG, Brown KA: Yersinia pestis and plague. Biochem Soc Trans 31:104-107, 2003
30. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252
31. Kimber I, Dearman RJ, Cumberbatch M, Huby RJ: Langerhans cells and chemical allergy. Curr Opin Immunol 1993, 10:614-619
32. Tablin F, Chamberlain JK, Weiss L: The microanatomy of the spleen: mechanisms of splenic clearance. The Complete Spleen: Structure, Function, and Clinical Disorders. Edited by AJ Bowdler. Totowa, NJ, Humana Press, 2002, pp 11-22
33. Groom AC, MacDonald IC, Schmidt EE: Splenic microcirculatory blood flow and function with the respect to red blood cells. The Complete Spleen: Structure, Function, and Clinical Disorders. Edited by AJ Bowdler. Totowa, NJ, Humana Press, 2002, pp 23-50
34. Dailey MO: The immune functions of the spleen. The Complete Spleen: Structure, Function, and Clinical Disorders. Edited by AJ Bowdler. Totawa, NJ, Humana Press, 2002, pp 51-70
35. Brubaker RR: Yersinia pestis and bubonic plague: the prokaryotes, an evolving electronic resource for the microbiological community. Edited by M Dworkin, S Falkow, E Rosenberg, KH Schleifer, E Stackebrandt. [online] cited 31 Jul 2003, http://et.springer-ny.com:8080/ prokPUB/index.htm
36. Nakajima R, Brubaker RR: Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993, 61:23-31
37. Nakajima R, Motin VL, Brubaker RR: Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 1995, 63:3021-3029
38. Monack DM, Mecsas J, Ghori N, Falkow S: Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci USA 1997, 94:10385-10390
39. Ruckdeschel K, Machold J, Roggenkamp A, Schubert S, Pierre J, Zumbihl R, Liaufard JP, Heesemann J, Rouot B: Yersinia enterocolitica promotes deactivation of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2, p38, and c-Jun NH2-terminal kinase: correlation with its inhibitory effect on tumor necrosis factor-alpha production. J Biol Chem 1997, 272:15920-15927
40. Palmer LE, Hobbie S, Galan JE, Bliska JB: YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 1998, 27:953-965
41. Boland A, Cornelis GR: Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun 1998, 66:1878-1884
42. Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Pettersson S, Wolf-Watz H: The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: yopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 1998, 28:1067-1079
43. Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE: Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 1999, 285: 1920-1923
44. Nedialkov YA, Motin VL, Brubaker RR: Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun 1997, 65:1196-1203
45. Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, Heesemann J: Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002, 196:1017-1024
46. Welkos S, Friedlander A, McDowell D, Weeks J, Tobery S: V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog 1998, 24:185-196
47. Opal SM, Cohen J: Clinical Gram-positive sepsis: does it fundamentally differ from Gram-negative bacterial sepsis? Crit Care Med 1999, 27:1608-1616